For instance, inhibiting endosome recycling by the anti-malarial small molecule primaquine in prostate cancer cells reduced the expression of androgen receptor, modulated lysosome degradation kinetics, and resulted in decreased cell survival independently. This evidence concerns the gene AR and prostate carcinoma.